Insights into interactions between taxanes and P-glycoprotein using biophysical and in silico methods
- 25 February 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (5) , 103708
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- University of Georgia
This publication has 97 references indexed in Scilit:
- Mutational analysis reveals the importance of residues of the access tunnel inhibitor site to human P‐glycoprotein (ABCB1)‐mediated transportProtein Science, 2024
- Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoproteinCancer Chemotherapy and Pharmacology, 2018
- The VSGB 2.0 model: A next generation energy model for high resolution protein structure modelingProteins: Structure, Function, and Bioinformatics, 2011
- Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from dockingJournal of Computational Chemistry, 2010
- Towards Prediction of In Vivo Intestinal Absorption Using a 96-Well Caco-2 AssayJournal of Pharmaceutical Sciences, 2010
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influenceEuropean Biophysics Journal, 2001
- The Extracellular Loop between TM5 and TM6 of P-Glycoprotein Is Required for Reactivity with Monoclonal Antibody UIC2Archives of Biochemistry and Biophysics, 1999
- Drug-stimulated ATPase activity of the human P-glycoproteinJournal of Bioenergetics and Biomembranes, 1995
- Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoproteinInternational Journal of Cancer, 1993